Loading company…
ProFound Therapeutics uses protein detection to identify potential drug targets.
Founded in 2020 and based in Massachusetts, US, ProFound Therapeutics applies protein detection technologies to study the human proteome and identify potential medicines. Its platform aims to discover and validate proteins and assess their roles in health and disease. Flagship Pioneering launched the company in May 2022 with an investment of USD 75 million.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in